Orchestra BioMed Holdings, Inc. (OBIO) short interest & options flow
NASDAQOBIO enters the week after its most active news session in months — a Q1 earnings beat, a fresh BACKBEAT trial update, and a Barclays target raise all landing within hours of each other. The catalyst was Tuesday's Q1 print. Orchestra BioMed reported EPS of -$0.33, beating the -$0.41 consensus estimate by $0.07. Revenue of $110K missed the $190K estimate — a thin figure that…
- Market cap
- $473M
- Next earnings
- 17 Nov 2026
Key data as of 12 Nov 2026

OBIO news and analysis
RSSNo long-form analysis yet for OBIO. Pulse alerts and the live data picture are available on ORTEX.
Open OBIO on ORTEX →Want the live picture for OBIO?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OBIO — free to start on ORTEX.
Sign up for free →Open OBIO on ORTEX